Carl Morrison

5PUBLICATIONS
0CO-AUTHORS
Molecular targetsCellular immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 03, 2019
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.

Sarabjot Pabla, Jeffrey M Conroy, Mary K Nesline

|Jan 26, 2019
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors.

Jeffrey M Conroy, Sarabjot Pabla, Mary K Nesline

|Jan 20, 2019
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.

Grace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos

|Jan 08, 2019
Identification of targets for prostate cancer immunotherapy.

Antonios Papanicolau-Sengos, Yuanquan Yang, Sarabjot Pabla

|May 11, 2018
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden.

Carl Morrison, Sarabjot Pabla, Jeffrey M Conroy

Pageof 1

Frequent Collaborators